Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Lasers Med Sci. 2012 Sep 4;28(4):1085–1089. doi: 10.1007/s10103-012-1193-1

TABLE 1.

Neuroprotective effect of agents tested on the RSCEM.

Treatment Time of treatment P50 increment Reference
t-PA 1 hr. 145% (14)
TNK 1 hr. 144% (22)
NXY-059 5 min 144% (23)
Memantine 1 hr. 180% (24)
Edaravone 3 hr. 133% (25)
Laser Single 25mW/cm2 1 hr. 108% (3)
Laser Double
7.5mW/cm2
2 & 5hr. 68% Current Study
Laser Triple 20mW/cm2 2, 3 & 4hr. 245% Current study

t-PA: tissue plasminogen activator, TNK: Tenecteplase, NXY: Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide